Chronic Pain Clinical Trial
Official title:
Reference Values and Clinical Screening Test of Diffuse Noxious Inhibitory Controls (DNIC) Using Deep Learning and Artificial Intelligence
NCT number | NCT04896827 |
Other study ID # | 2021-4227 |
Secondary ID | |
Status | Suspended |
Phase | |
First received | |
Last updated | |
Start date | April 5, 2022 |
Est. completion date | December 2024 |
Verified date | November 2023 |
Source | Université de Sherbrooke |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Chronic pain (CP) is disabling for people triggering important costs for society. A deficit of diffuse noxious inhibitory controls (DNIC) is one of the CP mechanisms. DNICs are evaluated in research setting using a CPM protocol (conditioned pain modulation). There is a lack of reference values on the effectiveness of DNICs. Wider research on DNIC will help to understand CP and to develop a clinical screening test evaluating DNICs. This study aims more specifically to determine whether it is possible to develop a facial recognition system to automate pain measurement and the effectiveness of pain control mechanisms.
Status | Suspended |
Enrollment | 244 |
Est. completion date | December 2024 |
Est. primary completion date | August 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 79 Years |
Eligibility | Healthy participants Inclusion Criteria: - 18-79 years old - No chronic pain - Able to provide consent Exclusion Criteria: - Cardiovascular disease (arrhythmia, cerebrovascular accident, infarction...) - Raynaud syndrome - Severe psychiatric disease (dementia, schizophrenia, psychosis, major depression) - Injuries or loss sensitivity to their forearms or hands - Pregnant women or in post-partum period (<1 year) Participants with chronic pain Inclusion Criteria: - 18-79 years old - Chronic pain (chronic pain is defined by any regular pain for more than 6 months) - Able to provide consent Exclusion Criteria: - Cardiovascular disease (arrhythmia, cerebrovascular accident, infarction...) - Raynaud syndrome - Severe psychiatric disease (dementia, schizophrenia, psychosis, major depression) - Injuries or loss sensitivity to their forearms or hands - Pregnant women or in post-partum period (<1 year) - Chronic pain caused by cancer or migraine |
Country | Name | City | State |
---|---|---|---|
Canada | Université de Sherbrooke | Sherbrooke | Quebec |
Lead Sponsor | Collaborator |
---|---|
Université de Sherbrooke | Centre for Research of CHUS (CRCHUS), Lucine |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Conditioned pain modulation (CPM) profiles | Sensitivity and specificity of the classification algorithm according to different profiles (normal vs altered) of conditioned pain modulation, as defined by the change of pain perception before and after the cold water bath measured by computerized visual analog scale (CoVAS) ranging from 0 [no pain] to 100 [most intense pain that could be tolerated] in healthy and in chronic pain volunteers together. | Once, at baseline, at recruitment (comparison between 1st and 2nd test, after the conditioning stimuli) | |
Primary | Temporal summation profiles | Sensitivity and specificity of the classification algorithm according to different profiles (normal vs altered) of temporal summation, as defined by the change of pain perception during the first stimuli test measured by computerized visual analog scale (CoVAS) ranging from 0 [no pain] to 100 [most intense pain that could be tolerated] in healthy and in chronic pain volunteers together. | Once, at baseline, at recruitment (during the first stimuli test) | |
Secondary | Conditioned pain modulation (CPM) profiles of healthy volunteers | Conditioned pain modulation, as defined by the change of pain perception before and after the cold water bath measured by computerized visual analog scale (CoVAS) ranging from 0 [no pain] to 100 [most intense pain that could be tolerated] only in healthy volunteers. | Once, at baseline, at recruitment (comparison between 1st and 2nd test, after the conditioning stimuli | |
Secondary | Temporal summation profiles of healthy volunteers | Temporal summation, as defined by the change of pain perception during the first stimuli test measured by computerized visual analog scale (CoVAS) ranging from 0 [no pain] to 100 [most intense pain that could be tolerated] only in healthy volunteers. | Once, at baseline, at recruitment (during the first stimuli test) | |
Secondary | Conditioned pain modulation (CPM) profiles of volunteers with chronic pain | Conditioned pain modulation, as defined by the change of pain perception before and after the cold water bath measured by computerized visual analog scale (CoVAS) ranging from 0 [no pain] to 100 [most intense pain that could be tolerated] only in volunteers with chronic pain. | Once, at baseline, at recruitment (comparison between 1st and 2nd test, after the conditioning stimuli) | |
Secondary | Temporal summation profiles of volunteers with chronic pain | Temporal summation, as defined by the change of pain perception during the first stimuli test measured by computerized visual analog scale (CoVAS) ranging from 0 [no pain] to 100 [most intense pain that could be tolerated] only in volunteers with chronic pain. | Once, at baseline, at recruitment (during the first stimuli test) | |
Secondary | Demographic factors | Association of demographic factors (age, gender) with different response profiles of CPM and temporal summation established by the algorithm. | Once, at baseline, at recruitment | |
Secondary | Psychologic factors | Association of psychologic factors (anxiety measured with HADS questionnaire) with different response profiles of CPM and temporal summation established by the algorithm. | Once, at baseline, at recruitment | |
Secondary | Physiologic factors | Association of physiologic factors (continuous blood pressure, heart rate, electrodermal activity) with different response profiles of CPM and temporal summation established by the algorithm. | Once, at baseline, at recruitment | |
Secondary | Facial expressions and postures | Association of facial expressions and postures with different response profiles of CPM and temporal summation established by the algorithm. | Once, at baseline, at recruitment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|